These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8434246)

  • 1. Rifampicin in early rheumatoid arthritis.
    Borg AA; Davis MJ; Fowler PD; Shadforth MF; Dawes PT
    Scand J Rheumatol; 1993; 22(1):39-42. PubMed ID: 8434246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy of cyclosporine A with methotrexate or hydroxychloroquine in refractory rheumatoid arthritis.
    Salaffi F; Carotti M; Cervini C
    Scand J Rheumatol; 1996; 25(1):16-23. PubMed ID: 8774550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of early rheumatoid arthritis with rifampicin.
    Cox NL; Prowse MV; Maddison MC; Maddison PJ
    Ann Rheum Dis; 1992 Jan; 51(1):32-4. PubMed ID: 1540033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial.
    Karlsson JA; Neovius M; Nilsson JÅ; Petersson IF; Bratt J; van Vollenhoven RF; Ernestam S; Geborek P
    Ann Rheum Dis; 2013 Dec; 72(12):1927-33. PubMed ID: 23196701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of hydroxychloroquine in early rheumatoid arthritis: the HERA Study.
    Am J Med; 1995 Feb; 98(2):156-68. PubMed ID: 7847432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy with hydroxychloroquine and methotrexate in rheumatoid arthritis.
    Trnavský K; Gatterová J; Lindusková M; Pelisková Z
    Z Rheumatol; 1993; 52(5):292-6. PubMed ID: 8259721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma hydroxychloroquine concentrations and efficacy in rheumatoid arthritis.
    Miller DR; Fiechtner JJ; Carpenter JR; Brown RR; Stroshane RM; Stecher VJ
    Arthritis Rheum; 1987 May; 30(5):567-71. PubMed ID: 3593438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of rifampicin with and without isoniazid in rheumatoid arthritis.
    McConkey B; Situnayake RD
    J Rheumatol; 1988 Jan; 15(1):46-50. PubMed ID: 3351840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxychloroquine may be associated with reduced risk of coronary artery diseases in patients with rheumatoid arthritis: A nationwide population-based cohort study.
    Hung YM; Wang YH; Lin L; Wang PYP; Chiou JY; Wei JC
    Int J Clin Pract; 2018 May; 72(5):e13095. PubMed ID: 29691971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open, randomized comparison study of cyclosporine A, cyclosporine A + methotrexate and cyclosporine A + hydroxychloroquine in the treatment of early severe rheumatoid arthritis.
    Sarzi-Puttini P; D'Ingianna E; Fumagalli M; Scarpellini M; Fiorini T; Chérié-Lignière EL; Panni B; Fiorentini F; Corbelli V; Beyene NB; Mastaglio C; Severi C; Locati M; Cazzola M; Menozzi G; Monti G; Saccardo F; Alfieri G; Atzeni F
    Rheumatol Int; 2005 Jan; 25(1):15-22. PubMed ID: 14530867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Hydroxychloroquine Retinal Toxicity by Automated Perimetry in 60 Rheumatoid Arthritis Patients with Normal Fundoscopic Findings.
    Motarjemizadeh Q; Aidenloo NS; Abbaszadeh M
    Glob J Health Sci; 2015 Jun; 8(3):59-64. PubMed ID: 26493438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of hydroxychloroquine use with lipid profiles in rheumatoid arthritis: pharmacologic implications.
    Kerr G; Aujero M; Richards J; Sayles H; Davis L; Cannon G; Caplan L; Michaud K; Mikuls T
    Arthritis Care Res (Hoboken); 2014 Nov; 66(11):1619-26. PubMed ID: 24692402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with cyclosporin switching to hydroxychloroquine in patients with rheumatoid arthritis.
    Kim WU; Seo YI; Park SH; Lee WK; Lee SK; Paek SI; Cho CS; Song HH; Kim HY
    Ann Rheum Dis; 2001 May; 60(5):514-7. PubMed ID: 11302876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfasalazine treatment for rheumatoid arthritis: a metaanalysis of 15 randomized trials.
    Weinblatt ME; Reda D; Henderson W; Giobbie-Hurder A; Williams D; Diani A; Docsa S
    J Rheumatol; 1999 Oct; 26(10):2123-30. PubMed ID: 10529127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should disease-modifying agents be used in mild rheumatoid arthritis?
    Davis MJ; Dawes PT; Fowler PD; Clarke S; Fisher J; Shadforth MF
    Br J Rheumatol; 1991 Dec; 30(6):451-4. PubMed ID: 1747702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxychloroquine sulfate in rheumatoid arthritis: long-term response rate and predictive parameters.
    Bell CL
    Am J Med; 1983 Jul; 75(1A):46-51. PubMed ID: 6346870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study.
    Tsakonas E; Fitzgerald AA; Fitzcharles MA; Cividino A; Thorne JC; M'Seffar A; Joseph L; Bombardier C; Esdaile JM
    J Rheumatol; 2000 Mar; 27(3):623-9. PubMed ID: 10743799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients.
    Morris SJ; Wasko MC; Antohe JL; Sartorius JA; Kirchner HL; Dancea S; Bili A
    Arthritis Care Res (Hoboken); 2011 Apr; 63(4):530-4. PubMed ID: 21452265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy in rheumatoid arthritis--no benefit of addition of hydroxychloroquine to patients with a suboptimal response to intramuscular gold therapy.
    Porter DR; Capell HA; Hunter J
    J Rheumatol; 1993 Apr; 20(4):645-9. PubMed ID: 8496858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: a randomized, double-blind six-week trial with eighteen-week extension.
    Furst DE; Lindsley H; Baethge B; Botstein GR; Caldwell J; Dietz F; Ettlinger R; Golden HE; McLaughlin GE; Moreland LW; Roberts WN; Rooney TW; Rothschild B; Sack M; Sebba AI; Weisman M; Welch KE; Yocum D
    Arthritis Rheum; 1999 Feb; 42(2):357-65. PubMed ID: 10025931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.